| Aktsiad | 405,182 M | — | MA Maxwealth | 0,6 | Tervishoiu | CSI Hong Kong Stock Connect Healthcare Index - CNY - Benchmark TR Net | 2.4.2025 | 1,39 | 0 | 0 |
IN | Aktsiad | 400,858 M | 17 717,46 | IN Invesco | 0,57 | Tervishoiu | Dynamic Pharmaceutical Intellidex Index (AMEX) | 23.6.2005 | 103,12 | 3,12 | 18,42 |
IN | Aktsiad | 376,667 M | — | IN Invesco | 0,14 | Tervishoiu | S&P Select Sector Capped 20% Health Care Index | 16.12.2009 | 720,81 | 5,12 | 22,97 |
VA | Aktsiad | 373,942 M | 6300,788 | VA VanEck | 0,35 | Tervishoiu | MVIS US Listed Biotech 25 | 20.12.2011 | 187,81 | 4,63 | 23,2 |
AM | Aktsiad | 354,989 M | — | AM Amundi | 0,18 | Tervishoiu | S&P Developed Ex-Korea LargeMidCap Sustainability Enhanced Health Care Index - EUR - Benchmark TR Net | 20.9.2022 | 10,66 | 4,64 | 21,76 |
IS | Aktsiad | 312,572 M | — | IS iShares | 0,25 | Tervishoiu | MSCI World Health Care ESG Reduced Carbon Select 20 35 Capped Index - Benchmark TR Net | 3.11.2021 | 5,21 | 4,73 | 22,23 |
SP | Aktsiad | 304,086 M | 68 745,9 | SP SPDR | 0,35 | Tervishoiu | S&P Pharmaceuticals Select Industry | 19.6.2006 | 51,92 | 3,51 | 16,73 |
HA | Aktsiad | 290,169 M | — | HA Harvest | 0,6 | Tervishoiu | SSE Science and Technology Innovation Board Biomedical Index Yield - CNY - Benchmark TR Net | 27.12.2023 | 1,05 | 0 | 0 |
| Aktsiad | 285,169 M | — | CA Capital | 1,01 | Tervishoiu | NASDAQ / Biotechnology | 9.1.2017 | 36,06 | 4,93 | 21,18 |
EV | Aktsiad | 267,114 M | — | EV Evolve | 0,74 | Tervishoiu | Solactive Global Healthcare 20 CAD Hedged Index - CAD | 25.10.2017 | 17,79 | 4,23 | 21,55 |
XT | Aktsiad | 260,137 M | — | XT Xtrackers | 0,2 | Tervishoiu | MSCI Europe Health Care ESG Screened 20-35 Index - EUR | 26.6.2007 | 224,14 | 4,15 | 19,55 |
IN | Aktsiad | 247,276 M | 7319,983 | IN Invesco | 0,58 | Tervishoiu | Dynamic Biotech & Genome Intellidex Index (AMEX) | 23.6.2005 | 78,89 | 4,4 | 17,88 |
SI | Aktsiad | 230,581 M | 158 683,9 | SI Simplify | 0,51 | Tervishoiu | | 7.10.2021 | 33,85 | 4,73 | 22,97 |
HF | Aktsiad | 230,116 M | — | HF Harvest Funds | 0,6 | Tervishoiu | CSI Vaccine and Biotechnology Index - CNY - Benchmark TR Gross | 16.2.2023 | 0,69 | 2,19 | 38,23 |
PA | Aktsiad | 208,109 M | — | PA Ping An | 0,6 | Tervishoiu | CSI Hong Kong Connect Healthcare - CNY - Benchmark TR Gross | 16.12.2021 | 0,92 | 2,48 | 20,11 |
HA | Aktsiad | 203,388 M | — | HA Harvest | 0,6 | Tervishoiu | CSI Medicine and Health 100 Strategy Index - CNY - Benchmark TR Gross | 24.4.2020 | 0,82 | 2,79 | 22,89 |
HA | Aktsiad | 203,275 M | — | HA Harvest | 0,6 | Tervishoiu | Hang Seng Healthcare Index - CNY - Benchmark TR Gross | 7.5.2024 | 1,55 | 2,67 | 20,3 |
| Aktsiad | 195,932 M | — | SY Sygnia | 0,53 | Tervishoiu | | 6.8.2021 | 29,49 | 4,3 | 21,13 |
CH | Aktsiad | 190,355 M | — | CH ChinaAMC | 0,6 | Tervishoiu | CSI Hong Kong Stock Connect Healthcare Index - CNY - Benchmark TR Net | 28.7.2025 | 0,89 | 0 | 0 |
LG | Aktsiad | 182,613 M | — | LG L&G | 0,49 | Tervishoiu | ROBO Global Healthcare Technology and Innovation ETF | 17.6.2019 | 13,87 | 3,12 | 25,07 |
GU | Aktsiad | 180,39 M | — | GU Guotai | 0 | Tervishoiu | Hang Seng Biotechnology Index - CNY - Benchmark TR Gross | 21.1.2026 | 1 | 0 | 0 |
HA | Aktsiad | 177,339 M | — | HA Hamilton | 0 | Tervishoiu | | 6.2.2024 | 13,45 | 4,53 | 21,67 |
HE | Aktsiad | 174,359 M | — | HE Harvest ETFs | 0 | Tervishoiu | | 21.8.2024 | 8,32 | 0 | 0 |
| Aktsiad | 173,447 M | — | HW Hwabao | 0,6 | Tervishoiu | CSI Hong Kong Connect Healthcare - CNY - Benchmark TR Gross | — | 0,93 | 0 | 0 |
TE | Aktsiad | 170,021 M | 25 898,86 | TE Tema | 0,75 | Tervishoiu | | 15.8.2023 | 37,07 | 6,58 | 19,8 |
BO | Aktsiad | 168,872 M | — | BO Bosera | 0,6 | Tervishoiu | CSI Pharmaceutical 50 Index - CNY - Benchmark TR Gross | 22.7.2021 | 0,58 | 3,89 | 25,29 |
BE | Aktsiad | 166,884 M | — | BE BetaShares | 0,57 | Tervishoiu | Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD | 4.8.2016 | 8,4 | 4,6 | 21,62 |
BM | Aktsiad | 166,722 M | — | BM BMO | 0,39 | Tervishoiu | Solactive Equal Weight U.S. Health Care Hedged to Canada Index - CAD | 19.5.2010 | 64,43 | 3,67 | 20,81 |
EF | Aktsiad | 165,576 M | — | EF E Fund | 0 | Tervishoiu | Hang Seng Biotech Index - CNY - Benchmark TR Gross | 20.10.2025 | 0,97 | 0 | 0 |
CH | Aktsiad | 157,244 M | — | CH ChinaAMC | 0,6 | Tervishoiu | | 4.3.2021 | 0,62 | 2,79 | 29,27 |
GU | Aktsiad | 155,729 M | — | GU Guotai | 0,6 | Tervishoiu | China Securities Vaccine and Biotechnology Index - Benchmark TR Gross | 10.8.2022 | 0,58 | 0 | 0 |
IC | Aktsiad | 155,317 M | — | IC ICBC | 0,52 | Tervishoiu | CSI Innovative Drug Industry Index - CNY - Benchmark TR Gross | 9.2.2021 | 0,57 | 3,14 | 28,61 |
IS | Aktsiad | 147,175 M | — | IS iShares | 0,25 | Tervishoiu | Dow Jones U.S. Select Medical Equipment Capped 35/20 Index | 3.8.2020 | 5,78 | 3,74 | 29,19 |
MI | Aktsiad | 146,218 M | — | MI Middlefield | 1,36 | Tervishoiu | | 12.2.2019 | 11,4 | 4,83 | 24,11 |
SP | Aktsiad | 138,96 M | 17 115,47 | SP SPDR | 0,35 | Tervishoiu | S&P Healthcare Equipment Select Industry | 26.1.2011 | 77,11 | 2,5 | 21,37 |
EF | Aktsiad | 132,345 M | — | EF E Fund | 0,6 | Tervishoiu | CSI Hong Kong Stock Connect Healthcare Index - CNY - Benchmark TR Net | 31.12.2025 | 0,86 | 0 | 0 |
DI | Aktsiad | 131,501 M | 46 503,64 | DI Direxion | 0,94 | Tervishoiu | S&P Health Care Select Sector | 15.6.2011 | 91,98 | 4,83 | 22,47 |
YI | Aktsiad | 126,431 M | 198 456,2 | YI YieldMax | 1 | Tervishoiu | | 23.10.2023 | 17,8 | 0 | 0 |
AL | Aktsiad | 126,275 M | 32 689,53 | AL ALPS | 0,5 | Tervishoiu | S-Network Medical Breakthroughs Index | 31.12.2014 | 48,43 | 4,17 | 0 |
AM | Aktsiad | 125,694 M | — | AM Amundi | 0,18 | Tervishoiu | S&P Developed Ex-Korea LargeMidCap Sustainability Enhanced Health Care Index - EUR - Benchmark TR Net | 20.9.2022 | 10,22 | 2,89 | 19,72 |
| Aktsiad | 125,348 M | — | SO SOL | 0,45 | Tervishoiu | FnGuide Medical Device Director Index - KRW - Benchmark Price Return | 22.8.2023 | 9285,07 | 2,31 | 17,09 |
LS | Aktsiad | 123,659 M | 1,913 M | LS Leverage Shares | 0,77 | Tervishoiu | | 22.7.2025 | 9,37 | 0 | 0 |
IN | Aktsiad | 121,859 M | 21 390,46 | IN Invesco | 0,29 | Tervishoiu | S&P SmallCap 600 Capped Health Care Index - Benchmark TR Gross | 7.4.2010 | 41,38 | 2,51 | 19,03 |
IN | Aktsiad | 118,813 M | 8232,714 | IN Invesco | 0,6 | Tervishoiu | Dorsey Wright Healthcare Tech Leaders TR | 12.10.2006 | 49,73 | 5,92 | 26,92 |
FU | Aktsiad | 116,426 M | — | FU Fullgoal | 0,6 | Tervishoiu | Hang Seng Biotech Index - CNY - Benchmark TR Gross | 24.12.2025 | 1 | 0 | 0 |
CS | Aktsiad | 114,353 M | — | CS China Southern | 0,6 | Tervishoiu | CSI Full Index of Medical and Healthcare Equipment and Service Index - CNY - Benchmark TR Gross | 22.10.2021 | 0,56 | 2,73 | 32,82 |
DE | Aktsiad | 112,666 M | 351 920,7 | DE Defiance | 1,32 | Tervishoiu | | 7.8.2024 | 17,88 | 0 | 0 |
IS | Aktsiad | 109,956 M | — | IS iShares | 0,18 | Tervishoiu | S&P 500 CAPPED 35/20 HEALTH CARE NTR | 15.6.2020 | 6,66 | 0 | 0 |
CI | Aktsiad | 105,957 M | — | CI CI | 0,83 | Tervishoiu | | 7.6.2018 | 10,52 | 3,88 | 17,87 |
TD | Aktsiad | 104,664 M | — | TD TD | 0,44 | Tervishoiu | Solactive Global Healthcare Leaders Index - CAD - Benchmark TR Net | 25.2.2021 | 18,83 | 3,51 | 20,54 |
HE | Aktsiad | 104,2 M | — | HE Harvest ETFs | 1,06 | Tervishoiu | | 17.1.2017 | 7,83 | 0 | 0 |
DI | Aktsiad | 101,538 M | 4,117 M | DI Direxion | 1,07 | Tervishoiu | S&P Biotechnology Select Industry | 28.5.2015 | 15,81 | 0 | 0 |
| Aktsiad | 100,554 M | — | SA Satrix | 0,48 | Tervishoiu | STOXX Global Breakthrough Healthcare (USD)(NR) | 26.5.2022 | 73,03 | 0 | 0 |
HE | Aktsiad | 93,232 M | — | HE Harvest ETFs | 2,69 | Tervishoiu | | 25.10.2022 | 8,28 | 0 | 0 |
| Aktsiad | 93,121 M | 6280,61 | FM F/m | 0,54 | Tervishoiu | | 30.10.2024 | 34,94 | 6,27 | 0 |
AM | Aktsiad | 90,301 M | — | AM Amundi | 0,3 | Tervishoiu | MSCI World Index / Health Care -SEC | 19.8.2010 | 542,98 | 7,37 | 31,3 |
KR | Aktsiad | 84,917 M | 38 651,35 | KR KraneShares | 0,65 | Tervishoiu | MSCI China All Shares Health Care 10/40 Index | 1.2.2018 | 17,96 | 3,41 | 26,6 |
CI | Aktsiad | 82,212 M | — | CI CI | 0,56 | Tervishoiu | Solactive Developed Markets Healthcare 150 CAD Index - CAD - Benchmark TR Net | 17.8.2021 | 23,7 | 0 | 0 |
PR | Aktsiad | 81,655 M | 10 204 | PR ProShares | 0,95 | Tervishoiu | NASDAQ / Biotechnology | 7.4.2010 | 81,82 | 0 | 0 |
SP | Aktsiad | 80,793 M | 7181,637 | SP SPDR | 0,35 | Tervishoiu | S&P Health Care Services Select Industry | 28.9.2011 | 98,47 | 2,54 | 15,55 |
MI | Aktsiad | 80,156 M | — | MI Middlefield | 1,42 | Tervishoiu | | 12.2.2019 | 10,94 | 0 | 0 |
CA | Aktsiad | 78,347 M | — | CA Cathay | 0 | Tervishoiu | ChiNext Medical and Healthcare Index - CNY - Benchmark TR Net | 2.4.2025 | 1,07 | 0 | 0 |
| Aktsiad | 78,227 M | — | KS KSM | 0,73 | Tervishoiu | S&P Health Care Select Sector | 4.12.2018 | 48,79 | 0 | 0 |
PR | Aktsiad | 74,895 M | 10 776,15 | PR ProShares | 0,95 | Tervishoiu | S&P Health Care Select Sector | 30.1.2007 | 43,84 | 0 | 0 |
IN | Aktsiad | 71,268 M | 26 417,01 | IN Invesco | 0,19 | Tervishoiu | NASDAQ / Biotechnology | 11.6.2021 | 29,1 | 4,91 | 21,12 |
AM | Aktsiad | 69,716 M | — | AM Amundi | 0,3 | Tervishoiu | STOXX Europe 600 / Health Care (Capped) - SS | 2.7.2020 | 191,91 | 2,98 | 20,61 |
DE | Aktsiad | 68,943 M | 32,327 M | DE Defiance | 1,29 | Tervishoiu | | 12.3.2025 | 19,42 | 0 | 0 |
BR | Aktsiad | 63,223 M | — | BR Brompton | 1,09 | Tervishoiu | | 3.4.2018 | 7,5 | 6,13 | 23,54 |
CH | Aktsiad | 62,414 M | — | CH ChinaAMC | 0 | Tervishoiu | Shanghai Stock Exchange Science and Technology Innovation Board Biopharmaceutical Index - CNY - Benchmark TR Gross | 14.5.2025 | 1,08 | 0 | 0 |
FI | Aktsiad | 57,362 M | 6479,251 | FI Fidelity | 0,5 | Tervishoiu | | 12.6.2023 | 24,72 | 4,23 | 37,59 |
IS | Aktsiad | 56,005 M | — | IS iShares | 0,35 | Tervishoiu | NASDAQ / Biotechnology | 6.3.2018 | 8,48 | 4,93 | 21,38 |
VI | Aktsiad | 54,569 M | 6341,096 | VI Virtus | 0,34 | Tervishoiu | LifeSci Biotechnology Products Index | 17.12.2014 | 83,91 | 5,54 | 0 |
RO | Aktsiad | 52,967 M | 27 629,19 | RO Roundhill | 0,59 | Tervishoiu | | 21.5.2024 | 31,89 | 4,01 | 14,05 |
RG | Aktsiad | 51,414 M | 7854,962 | RG ROBO Global | 0,68 | Tervishoiu | ROBO Global Healthcare Technology and Innovation ETF | 25.6.2019 | 33,12 | 3,1 | 25,46 |
TE | Aktsiad | 51,274 M | 7437,868 | TE Tema | 0,75 | Tervishoiu | | 21.11.2023 | 33,81 | 6,56 | 21,55 |
VA | Aktsiad | 50,79 M | — | VA VanEck | 0,45 | Tervishoiu | MarketGrader Developed Markets ex-Australia Health Care Index - AUD | 8.9.2020 | 11,35 | 4,95 | 21,34 |
MI | Aktsiad | 45,614 M | — | MI Middlefield | 1,46 | Tervishoiu | | 20.10.2016 | 12,47 | 4,47 | 21,53 |
GX | Aktsiad | 40,925 M | — | GX Global X | 0,45 | Tervishoiu | S&P Biotechnology Select Industry | 8.11.2018 | 63,08 | 5,08 | 0 |
FU | Aktsiad | 40,699 M | — | FU Fullgoal | 0,6 | Tervishoiu | CSI Vaccine and Biotechnology Index - CNY - Benchmark TR Gross | 16.9.2022 | 0,66 | 2 | 29,03 |
TR | Aktsiad | 38,909 M | 498 586,1 | TR Tradr | 1,3 | Tervishoiu | | 12.5.2025 | 15,86 | 0 | 0 |
IS | Aktsiad | 37,573 M | 3240,71 | IS iShares | 0,18 | Tervishoiu | | 21.3.2018 | 34,58 | 5,85 | 16,28 |
DE | Aktsiad | 37,161 M | 953 557,6 | DE Defiance | 1,3 | Tervishoiu | | 3.12.2024 | 10,29 | 0 | 0 |
IS | Aktsiad | 36,661 M | 7601,91 | IS iShares | 0,18 | Tervishoiu | | 21.3.2018 | 41,34 | 4,27 | 23,49 |
PU | Aktsiad | 36,237 M | — | PU Purpose | 0 | Tervishoiu | | 7.2.2025 | 7,98 | 0 | 0 |
VI | Aktsiad | 35,936 M | 19 704,68 | VI Virtus | 0,65 | Tervishoiu | LifeSci Biotechnology Clinical Trials Index | 16.12.2014 | 42,83 | 4,22 | 0 |
EV | Aktsiad | 32,669 M | — | EV Evolve | 0,72 | Tervishoiu | Solactive Global Healthcare 20 Index - CAD | 25.10.2017 | 22,6 | 0 | 0 |
| Aktsiad | 31,721 M | — | TA Tachlit | 1,23 | Tervishoiu | NASDAQ / Biotechnology | 13.11.2018 | 152,42 | 0 | 0 |
HE | Aktsiad | 30,633 M | — | HE Harvest ETFs | 0 | Tervishoiu | | 21.8.2024 | 9,22 | 0 | 0 |
YI | Aktsiad | 29,471 M | 59 230,09 | YI YieldMax | 1,01 | Tervishoiu | | 22.9.2025 | 13,06 | 0 | 0 |
FT | Aktsiad | 29,344 M | 8405,426 | FT First Trust | 0,6 | Tervishoiu | Nasdaq US Smart Pharmaceuticals Index | 20.9.2016 | 34,17 | 4,73 | 18,68 |
BM | Aktsiad | 28,207 M | — | BM BMO | 0,78 | Tervishoiu | | 23.1.2023 | 26,39 | 4,17 | 22,59 |
HA | Aktsiad | 27,528 M | 5726,471 | HA Harbor | 0,8 | Tervishoiu | | 17.11.2022 | 29,65 | 11,65 | 33,3 |
HA | Aktsiad | 25,993 M | — | HA Hanwha | 0,4 | Tervishoiu | KRX 300 Healthcare Index - KRW - Benchmark TR Gross | 8.11.2018 | 7972,52 | 4,05 | 49,35 |
XT | Aktsiad | 25,412 M | — | XT Xtrackers | 0,35 | Tervishoiu | MSCI ACWI IMI SDG 3 Good Health and Well-being Select Index - Benchmark TR Net | 18.1.2023 | 35,36 | 4,42 | 20,67 |
GX | Aktsiad | 23,889 M | 14 861,33 | GX Global X | 0,5 | Tervishoiu | Global X HealthTech Index - Benchmark TR Net | 29.7.2020 | 23,83 | 3,67 | 26,47 |
JH | Aktsiad | 23,444 M | 12 449,4 | JH John Hancock | 0,4 | Tervishoiu | John Hancock Dimensional Healthcare Index | 29.9.2015 | 44,4 | 4,05 | 17,36 |
| Aktsiad | 23,081 M | — | SM Smart | 0,75 | Tervishoiu | STOXX Global Breakthrough Healthcare (USD)(NR) | 6.6.2019 | 3,37 | 0 | 0 |
GS | Aktsiad | 21,418 M | 2982,191 | GS Goldman Sachs | 0,75 | Tervishoiu | | 9.11.2021 | 32,93 | 7,3 | 29,06 |
AD | Aktsiad | 20,633 M | 11 529,15 | AD AdvisorShares | 1 | Tervishoiu | | 15.9.2021 | 17,4 | 3,48 | 0 |
FU | Aktsiad | 20,482 M | — | FU Fubon | 0,6 | Tervishoiu | CSI Pharmaceutical and Medical Device Innovation Index - CNY - Benchmark TR Gross | 3.3.2022 | 0,69 | 0 | 0 |